Review Article
Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
Table 3
Potential Therapeutic Strategies and agent examples for TNBC.
| Potential therapeutic strategies | Agent examples |
| Src inhibition | Dasatinib; Saracatanib | PARP inhibition | Olaparib; ABT-888 | Androgen receptor inhibition | Bicalutamide | Targeting epigenetics | Decitabine LBH589 | EGFR pathway inhibition | Cetuximab | PI3K pathway inhibition | NVP-BEZ235; Everolimus |
|
|